Glass Geoffrey Michael's Form 4/A amendment
AmendedAvadel Pharmaceuticals PLC (AVDL) · filed Jun 3, 2022
- Accession no.
- 0001104659-22-068189
- Filed
- Jun 3, 2022
- Trade date
- May 31, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jun 2, 2022
This filing lists 1 non-derivative transaction. Open-market purchases total $96.3K. It was filed 3 days after the trade.
This amendment replaces 0001104659-22-067598 (filed Jun 2, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glass Geoffrey MichaelCIK 0001517718 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | ADSs | PPurchaseAcquired | +45,000 | $2.14F2 | +$96,300 | 45,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust.
Remarks
The Form 4 filed on June 2, 2022 inadvertently reported that the transaction occurred on June 1, 2022. The transaction occurred on May 31, 2022.